Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > ATM used?

<< Previous

Bullboard Posts

Next >>

Comment by Wino115on Sep 05, 2023 12:58pm

169 Views

Post# 35620118

RE:RE:RE:RE:RE:RE:ATM used?

Good working Capital mgmt is ok. Although hard to repeat but maybe they are more reliant on smaller, more frequent inventory orders to meet demand.

We will know soon enough. Given they are now focused on news flow I would guess we will hear about trial enrollment - both starting, filling up, results.

if the selling is from a Canadian broker in TSX shares then it's not the ATM as that is Cantor led and sold NASDAQ.

<< Previous

Bullboard Posts

Next >>

Calibre discovers significant gold in Newfoundland